Barclays’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $804K | Sell |
138,553
-224,198
| -62% | -$1.49M | ﹤0.01% | 2887 |
|
|
2025
Q4 | $2.85M | Buy |
362,751
+16,112
| +5% | +$127K | ﹤0.01% | 2670 |
|
|
2025
Q3 | $2.82M | Sell |
346,639
-77,609
| -18% | -$516K | ﹤0.01% | 2609 |
|
|
2025
Q2 | $1.98M | Buy |
424,248
+143,613
| +51% | +$658K | ﹤0.01% | 2853 |
|
|
2025
Q1 | $1.54M | Sell |
280,635
-67,007
| -19% | -$270K | ﹤0.01% | 2834 |
|
|
2024
Q4 | $1.18M | Buy |
347,642
+23,170
| +7% | +$74.5K | ﹤0.01% | 3271 |
|
|
2024
Q3 | $925K | Buy |
324,472
+151,685
| +88% | +$390K | ﹤0.01% | 3404 |
|
|
2024
Q2 | $389K | Sell |
172,787
-32,186
| -16% | -$64.9K | ﹤0.01% | 3198 |
|
|
2024
Q1 | $453K | Sell |
204,973
-70,990
| -26% | -$184K | ﹤0.01% | 3656 |
|
|
2023
Q4 | $649K | Buy |
275,963
+170,220
| +161% | +$314K | ﹤0.01% | 3716 |
|
|
2023
Q3 | $197K | Buy |
105,743
+13,040
| +14% | +$29.9K | ﹤0.01% | 3308 |
|
|
2023
Q2 | $243K | Sell |
92,703
-47,029
| -34% | -$120K | ﹤0.01% | 3152 |
|
|
2023
Q1 | $228K | Buy |
139,732
+31,421
| +29% | +$39.3K | ﹤0.01% | 3714 |
|
|
2022
Q4 | $144K | Buy |
108,311
+47,566
| +78% | +$67.1K | ﹤0.01% | 4019 |
|
|
2022
Q3 | $95K | Buy |
60,745
+31,151
| +105% | +$51.5K | ﹤0.01% | 3561 |
|
|
2022
Q2 | $46K | Buy |
29,594
+7,806
| +36% | +$16.5K | ﹤0.01% | 4069 |
|
|
2022
Q1 | $56K | Buy |
+21,788
| New | +$53.2K | ﹤0.01% | 4070 |
|
|
2021
Q4 | – | Sell |
-29,541
| Closed | -$72K | – | 4796 |
|
|
2021
Q3 | $72K | Buy |
29,541
+24,418
| +477% | +$70.9K | ﹤0.01% | 4018 |
|
|
2021
Q2 | $21K | Sell |
5,123
-33,627
| -87% | -$128K | ﹤0.01% | 4486 |
|
|
2021
Q1 | $174K | Buy |
38,750
+23,747
| +158% | +$128K | ﹤0.01% | 3775 |
|
|
2020
Q4 | $74K | Sell |
15,003
-6,107
| -29% | -$30.6K | ﹤0.01% | 4255 |
|
|
2020
Q3 | $126K | Buy |
21,110
+532
| +3% | +$2.13K | ﹤0.01% | 4125 |
|
|
2020
Q2 | $55K | Buy |
20,578
+9,174
| +80% | +$31.9K | ﹤0.01% | 4886 |
|
|
2020
Q1 | $22K | Sell |
11,404
-15,288
| -57% | -$65.7K | ﹤0.01% | 5616 |
|
|
2019
Q4 | $188K | Buy |
26,692
+13,153
| +97% | +$109K | ﹤0.01% | 5077 |
|
|
2019
Q3 | $133K | Sell |
13,539
-3,651
| -21% | -$41K | ﹤0.01% | 5263 |
|
|
2019
Q2 | $197K | Buy |
17,190
+11,104
| +182% | +$117K | ﹤0.01% | 5125 |
|
|
2019
Q1 | $61K | Buy |
6,086
+5,244
| +623% | +$67.2K | ﹤0.01% | 5730 |
|
|
2018
Q4 | $15K | Sell |
842
-1,636
| -66% | -$32.8K | ﹤0.01% | 6034 |
|
|
2018
Q3 | $44K | Buy |
+2,478
| New | +$53.8K | ﹤0.01% | 6157 |
|
Other funds holding XERS
VCM
RA
N
VPM
